Human pre-malignant breast diseases, particularly ductal carcinoma in situ
(DCIS)(3) already display several of the aberrant phenotypes found in prima
ry breast cancers, including chromosomal abnormalities, telomerase activity
, inactivation of the p53 gene, and overexpression of some oncogenes. Effor
ts to model early breast carcinogenesis in human cell cultures have largely
involved studies of in vitro transformation of normal finite lifespan huma
n mammary epithelial cells (HMEC) to immortality and malignancy. We present
a model of HMEC immortal transformation consistent with the known in vivo
data. This model includes a recently described, presumably epigenetic proce
ss, termed conversion, which occurs in cells that have overcome stringent r
eplicative senescence and are thus able to maintain proliferation with crit
ically short telomeres. The conversion process involves reactivation of tel
omerase activity, and acquisition of good uniform growth in the absence and
presence of TGF beta. We propose that overcoming the proliferative constra
ints set by senescence, and undergoing conversion, represent key rate-limit
ing steps in human breast carcinogenesis, and occur during early stage brea
st cancer progression.